Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to learn if patients being treated with second generation antipsychotics and with clinically meaningful elevations/levels in any metabolic syndrome elements will have better access to medical treatment more quickly if they are randomized to one of the following conditions: 1) a primary care provider located in the community mental health center where mental health treatment is provided (IMBED), 2) a medical care manager to help coordinate treatment with an outside primary care provider (Liaison) or 3) the standard practice of advising the patient to see a primary care doctor (Treatment as Usual).


Clinical Trial Description

Individuals will be identified for participation based upon baseline laboratory values obtained at the local Community Mental Health Clinic (CMHC) as part of the standard monitoring procedures for individuals on Second Generation Antipsychotics (SGAs). Following randomization, a research assistant will be assigned to obtain information on primary care provider visits, medications and lab tests conducted outside of the CMHC using a signed release for from the patient. Variables collected include: date and time of all physician or practitioner visits, type of practitioner, all medication prescriptions, and all laboratory values and vital signs related to metabolic syndrome parameters. Data will be put into an access data base for analysis. Data from private pharmacies will be obtained using a separate signed consent form. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


NCT number NCT01115114
Study type Interventional
Source The University of Texas Health Science Center at San Antonio
Contact
Status Completed
Phase N/A
Start date January 2009
Completion date January 2014

See also
  Status Clinical Trial Phase
Completed NCT02420340 - Using The HOPES Program in Transition Care N/A
Completed NCT01686815 - Cross-Sectional Iloperidone IVGTT
Completed NCT03069482 - Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness Phase 1
Completed NCT01043653 - Assessing Recovery N/A
Completed NCT02188121 - Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients Phase 4
Recruiting NCT03627377 - Multi-component Intervention for Diabetes in Adults With Serious Mental Illness N/A
Completed NCT02127671 - Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness N/A
Not yet recruiting NCT05807867 - RCT of an Intersectional Stigma Intervention to Sustain Viral Suppression Among Women Living With Serious Mental Illness and HIV in Botswana N/A
Not yet recruiting NCT06078293 - Home-based Exercise for SMI N/A
Completed NCT02469389 - Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia N/A
Completed NCT01566513 - Effectiveness and Cost Effectiveness of Peer Mentors in Reducing Hospital Use N/A
Completed NCT00520728 - Efficacy of an Occupational Time Use Intervention for People With Serious Mental Illness Phase 1
Recruiting NCT04560335 - Coach to Fit Weight Loss Intervention for Individuals With Serious Mental Illness Phase 3
Recruiting NCT03467243 - Evaluating the Use of Peer Specialists to Deliver Cognitive Behavioral Social Skills Training N/A
Completed NCT02022462 - Project Bridge: Peer Health Navigator Intervention N/A